Pathophysiology of asthma in PG level

Reading File

Finding Sources

Searching PubMed

"asthma"[MeSH Terms] AND "pathophysiology"[MeSH Terms]

Reading File

Searching Images

asthma pathophysiology airway inflammation diagram

Reading File

I now have comprehensive material from top-tier sources. Let me compile the complete PG-level answer:

Pathophysiology of Asthma

Sources: Robbins & Cotran Pathologic Basis of Disease (10th ed.), Fishman's Pulmonary Diseases and Disorders, Murray & Nadel's Textbook of Respiratory Medicine

Definition & Core Triad

Asthma is a chronic inflammatory disease of the airways characterized by three interacting pathophysiologic components:

Airway hyperresponsiveness (AHR)
Variable airflow obstruction (reversible bronchoconstriction)
Chronic airway inflammation with structural remodeling

The complex interplay between these factors — not any one element alone — defines the clinical expression of disease.

Types of Asthma

Type	Mechanism
Atopic (Allergic)	Th2/IgE-mediated; most common (65–80%)
Non-atopic (Intrinsic)	Non-IgE; triggered by cold, exercise, pollutants
Drug-induced	ASA/NSAIDs via COX inhibition → ↑ leukotrienes
Occupational	Sensitization to workplace antigens

Central Immunopathogenesis: T2 Inflammatory Pathway

Step 1 — Allergen Sensitization (Adaptive Response)

Inhaled allergen is trapped in the mucus layer and endocytosed by dendritic cells (DCs) whose dendrites interdigitate between bronchial epithelial cells.
DCs migrate to local lymph nodes, presenting antigen via MHC II to naïve CD4⁺ T cells.
Under the influence of IL-4 (from mast cells and basophils), naïve T cells differentiate into Th2 cells.
Th2 cells secrete the critical cytokine triad:
- IL-4 → drives IgE class switching in B cells; promotes AHR in smooth muscle
- IL-5 → eosinophil maturation, recruitment, and activation
- IL-13 → goblet cell mucus hypersecretion; promotes IgE production
IgE produced by plasma cells binds the high-affinity FcεRI receptors on submucosal mast cells and circulating basophils.

Step 2 — Re-exposure: Mast Cell Activation

On re-exposure, allergen cross-links IgE on mast cells → degranulation.

Preformed mediators released:

Histamine
Tryptase, chymase, heparin
TNF-α, VEGF

Newly synthesized mediators:

Leukotrienes (LTC4, LTD4, LTE4): potent, prolonged bronchoconstriction + ↑ vascular permeability + ↑ mucus
PGD2: bronchoconstriction + vasodilation
Thromboxane A2, PAF
Cytokines: IL-4, IL-5, IL-8, IL-13, GM-CSF

Pathophysiology of asthma — early and late stage immune responses

Biphasic Bronchial Response

Early Phase Reaction (Minutes 0–30)

Bronchoconstriction: mast cell–released histamine and leukotrienes act directly + via vagal reflexes on subepithelial parasympathetic receptors → airway smooth muscle (ASM) contraction
Increased vascular permeability → edema
Mucus hypersecretion (goblet cell stimulation)
Vasodilation

Late Phase Reaction (Hours 2–8)

Recruitment of eosinophils, neutrophils, basophils, lymphocytes, monocytes to the airway wall
Eosinophil-derived:
- Major Basic Protein (MBP), Eosinophil Cationic Protein (ECP) → epithelial damage, ciliary dysfunction
- LTC4 → bronchoconstriction
- Reactive oxygen species (ROS) → oxidative stress
Charcot-Leyden crystals (crystallized galectin-10/GAL10 from eosinophils) → strong inducers of inflammation and mucus production
This phase underlies persistent AHR and sets the stage for remodeling

Key Cellular Players

Cell	Role in Asthma
Mast cells	Early-phase trigger; preformed + newly synthesized mediators
Th2 / ILC2 cells	Master regulators of T2 inflammation; IL-4, IL-5, IL-13
Eosinophils	Late-phase tissue damage; MBP, ECP, LTC4, ROS
Basophils	IgE-dependent histamine + IL-4/IL-13 release; Th2 polarization
Dendritic cells	Antigen presentation; Th2 polarization
Macrophages	Source of ROS; amplify inflammation
Neutrophils	Recruited by LTB4; prominent in severe/steroid-resistant asthma
Airway epithelial cells	Release alarmins (TSLP, IL-25, IL-33) after injury

Innate Immune Contribution: Alarmins & ILC2s

Damaged epithelial cells release epithelial-derived alarmins:

TSLP (thymic stromal lymphopoietin)
IL-33
IL-25

These activate type 2 innate lymphoid cells (ILC2s), which produce IL-4, IL-5, and IL-13 without antigen recognition. This explains non-allergic asthma and explains why inflammation can occur even without adaptive immune sensitization.

Allergic vs non-allergic asthma — alarmin-mediated pathways

Airway Hyperresponsiveness (AHR)

AHR is defined as an exaggerated bronchoconstrictor response to stimuli (cold air, exercise, methacholine, histamine) that would be innocuous in normal individuals.

Mechanisms include:

Subepithelial exposure of sensory nerves (from epithelial damage) → exaggerated reflex bronchoconstriction
ASM hypertrophy + hyperplasia → increased contractile mass
Increased mucosal permeability (allows allergens/irritants deeper access)
Neural plasticity: upregulation of substance P and other neuropeptides
Persistent eosinophilic inflammation lowering the threshold of ASM contraction

Mediator Profile Summary

Mediator	Source	Effect
Histamine	Mast cells, basophils	Bronchoconstriction, edema
LTC4/LTD4/LTE4	Mast cells, eosinophils	Prolonged bronchoconstriction, mucus, edema
LTB4	Neutrophils	Neutrophil chemotaxis
PGD2	Mast cells	Bronchoconstriction, vasodilation
IL-5	Th2, ILC2	Eosinophil maturation/activation
IL-13	Th2, ILC2	Mucus hypersecretion, AHR
Acetylcholine	Parasympathetic nerves	ASM contraction via muscarinic receptors
MBP / ECP	Eosinophils	Epithelial necrosis, ciliostasis
GAL10 (Charcot-Leyden)	Eosinophils	Inflammation, mucus induction
TGF-β	Multiple cells	Subepithelial fibrosis (remodeling)

Genetics & Environment

Asthma is polygenic — multiple loci on chromosomes 5q, 6p, 11q, 12q, 14q, and 16p are implicated.
Gene-environment interactions are critical: the same genetic predisposition can result in very different phenotypes depending on:
- Allergen load and type (house dust mite, pollens, cockroach, pet dander)
- Hygiene hypothesis: reduced microbial exposure in early life fails to skew immunity away from Th2, promoting atopy
- Viral URTIs (particularly rhinovirus) → major trigger of exacerbations via TLR3-mediated epithelial alarmin release

Airway Remodeling (Chronic Asthma)

With persistent disease, structural changes accrue and add an irreversible component to obstruction:

Histology of asthmatic bronchus showing goblet cell hyperplasia, fibrosis, eosinophils, muscle hypertrophy

Histology (Robbins Fig. 15.11): (A) Asthmatic bronchus — goblet cell hyperplasia (green arrow), sub-basement membrane fibrosis (black arrow), eosinophilic inflammation (yellow arrow), muscle hypertrophy (blue arrow). (B) Sputum: Charcot-Leyden crystals.

Structural Change	Mechanism	Consequence
Goblet cell hyperplasia	IL-13, IL-4	Mucus plugging
Sub-basement membrane fibrosis	TGF-β → collagen deposition	Irreversible narrowing
ASM hypertrophy + hyperplasia	Growth factors, chronic contraction	↑ AHR, fixed obstruction
Submucosal gland hypertrophy	Cholinergic + inflammatory stimuli	Mucus hypersecretion
Angiogenesis	VEGF from mast cells	Mucosal edema
Nerve remodeling	Substance P, VIP changes	Neural AHR

Growth factors driving remodeling: TGF-β, EGF, FGF-2, VEGF, PDGF.

Aspirin-Exacerbated Respiratory Disease (AERD)

A distinct phenotype with:

Chronic rhinosinusitis + nasal polyps + severe asthma
Mechanism: Aspirin/NSAIDs inhibit COX → ↓ PGE2 → loss of tonic inhibition of 5-lipoxygenase → massive surge in cysteinyl leukotrienes (LTC4/D4/E4)
Mast cells are the primary source of cysteinyl leukotrienes in this syndrome
Diagnosed by elevated urinary LTE4

Non-T2 (Th1/Th17) Pathway

In ~20–35% of asthmatic patients (typically severe, steroid-resistant):

Th17 cells → IL-17 → neutrophil recruitment → neutrophilic inflammation
Th1 cells → IFN-γ → further epithelial damage
Often associated with obesity, smoking, pollutant exposure
Less responsive to inhaled corticosteroids

Biologic therapy targets in asthma — Tezepelumab, Dupilumab, Mepolizumab, Omalizumab

Physiologic Consequences

FEV1/FVC ratio < 0.70 (obstructive pattern); reversible with bronchodilator (≥12% + 200 mL improvement)
Air trapping → ↑ RV, ↑ FRC
Ventilation-perfusion mismatch → hypoxemia
Hypocapnia (early, due to hyperventilation); hypercapnia in severe/status asthmaticus (fatigue, impending respiratory failure)
Pulsus paradoxus > 10 mmHg in severe attacks
Mucus plugging → atelectasis

Summary Diagram Logic

Allergen → Dendritic cell → Th2 polarization → IgE production → Mast cell sensitization ↓ (Re-exposure) IgE cross-linking → Mast cell degranulation ↓ Early phase: Bronchoconstriction + edema + mucus (0–30 min) ↓ Late phase: Eosinophil/neutrophil infiltration + epithelial damage (2–8 h) ↓ (Repeated) Chronic inflammation → Airway remodeling → Fixed obstruction

Key references: Robbins, Cotran & Kumar — Pathologic Basis of Disease, 10th ed., p. 639–641; Fishman's Pulmonary Diseases and Disorders, Ch. 43; Murray & Nadel's Textbook of Respiratory Medicine

Give me a clear flowchart for ppt

Reading File

Running Command

ls /home/daytona/workspace/ 2>/dev/null || mkdir -p /home/daytona/workspace/asthma-ppt

Running Command

mkdir -p /home/daytona/workspace/asthma-ppt

Writing File

~/asthma-ppt/asthma_flowchart.js

const pptxgen = require("pptxgenjs");

const pres = new pptxgen();
pres.layout = "LAYOUT_WIDE"; // 13.3" x 7.5"
pres.title = "Pathophysiology of Asthma";

// ─── COLOR PALETTE ───────────────────────────────────────────────────────────
const C = {
  bg:        "0D1B2A",   // deep navy background
  panel:     "112233",   // slightly lighter panel
  blue1:     "1565C0",   // sensitization
  blue2:     "1976D2",
  teal:      "00838F",   // mast cell
  orange:    "E65100",   // early phase
  purple:    "6A1B9A",   // late phase
  red:       "B71C1C",   // remodeling
  gold:      "F9A825",   // accent / arrow
  white:     "FFFFFF",
  lt:        "E3EAF4",   // light text
  dim:       "8EA8C3",   // dimmed text
};

// helper: draw a rounded box node
function node(slide, x, y, w, h, color, title, sub, titleSize = 11, subSize = 9) {
  slide.addShape("roundRect", {
    x, y, w, h, rectRadius: 0.12,
    fill: { color },
    shadow: { type: "outer", color: "000000", blur: 8, offset: 3, angle: 135, opacity: 0.35 }
  });
  const lines = [];
  lines.push({ text: title, options: { bold: true, fontSize: titleSize, color: C.white, breakLine: sub ? true : false } });
  if (sub) lines.push({ text: sub, options: { fontSize: subSize, color: "DDDDDD" } });
  slide.addText(lines, { x, y, w, h, align: "center", valign: "middle", margin: 4 });
}

// helper: vertical arrow
function arrowDown(slide, cx, y, len, color = C.gold) {
  slide.addShape("line", {
    x: cx, y, w: 0, h: len,
    line: { color, width: 2.5, endArrowType: "triangle" }
  });
}

// helper: horizontal arrow (right)
function arrowRight(slide, x, cy, len, color = C.gold) {
  slide.addShape("line", {
    x, y: cy, w: len, h: 0,
    line: { color, width: 2.5, endArrowType: "triangle" }
  });
}

// helper: label on arrow
function arrowLabel(slide, x, y, w, text) {
  slide.addText(text, { x, y, w, h: 0.3, fontSize: 8, color: C.gold, align: "center", bold: true });
}

// ═══════════════════════════════════════════════════════════════════════════
// SLIDE 1 — TITLE
// ═══════════════════════════════════════════════════════════════════════════
{
  const s = pres.addSlide();
  s.background = { color: C.bg };

  // Top accent bar
  s.addShape("rect", { x: 0, y: 0, w: 13.3, h: 0.08, fill: { color: C.gold } });

  // Main title
  s.addText("Pathophysiology of Asthma", {
    x: 0.7, y: 1.8, w: 11.9, h: 1.4,
    fontSize: 44, bold: true, color: C.white, align: "center",
    fontFace: "Calibri"
  });

  // Subtitle
  s.addText("A Systematic Flowchart for PG-Level Understanding", {
    x: 0.7, y: 3.3, w: 11.9, h: 0.6,
    fontSize: 20, color: C.gold, align: "center", italic: true
  });

  // Three pillars
  const pillars = [
    { x: 1.2,  label: "Airway\nHyperresponsiveness", color: C.blue1 },
    { x: 5.15, label: "Variable Airflow\nObstruction",       color: C.teal  },
    { x: 9.1,  label: "Chronic Airway\nInflammation",        color: C.purple },
  ];
  pillars.forEach(p => {
    s.addShape("roundRect", { x: p.x, y: 4.2, w: 3.0, h: 0.9, rectRadius: 0.12, fill: { color: p.color } });
    s.addText(p.label, { x: p.x, y: 4.2, w: 3.0, h: 0.9, fontSize: 12, bold: true, color: C.white, align: "center", valign: "middle" });
  });

  // Core triad label
  s.addText("CORE TRIAD", { x: 0.5, y: 3.9, w: 12.3, h: 0.28, fontSize: 10, color: C.dim, align: "center", bold: true, charSpacing: 4 });

  // Bottom bar
  s.addShape("rect", { x: 0, y: 7.42, w: 13.3, h: 0.08, fill: { color: C.gold } });
  s.addText("Robbins & Cotran  |  Fishman's Pulmonary  |  Murray & Nadel", {
    x: 0.5, y: 7.1, w: 12.3, h: 0.3, fontSize: 9, color: C.dim, align: "center"
  });
}

// ═══════════════════════════════════════════════════════════════════════════
// SLIDE 2 — MASTER FLOWCHART (Main Pathogenesis)
// ═══════════════════════════════════════════════════════════════════════════
{
  const s = pres.addSlide();
  s.background = { color: C.bg };

  // Title bar
  s.addShape("rect", { x: 0, y: 0, w: 13.3, h: 0.55, fill: { color: C.blue1 } });
  s.addText("Asthma Pathogenesis — Master Flowchart", {
    x: 0.2, y: 0, w: 12.9, h: 0.55, fontSize: 18, bold: true, color: C.white, valign: "middle"
  });

  // ── COLUMN LAYOUT (5 rows, center column) ───────────────────────────────
  const cx = 5.05; // center x of main column
  const nw = 3.2;  // node width
  const nh = 0.62; // node height

  // Row y positions
  const rows = [0.75, 1.6, 2.45, 3.3, 4.15, 5.0, 5.85, 6.5];

  // ── MAIN CHAIN ──────────────────────────────────────────────────────────
  // 1. Trigger
  node(s, cx, rows[0], nw, nh, "1A3A5C", "TRIGGER / ALLERGEN", "House dust mite · pollens · pet dander · viruses");
  arrowDown(s, cx + nw/2, rows[0] + nh, 0.22);

  // 2. Epithelial damage → Alarmins
  node(s, cx, rows[1], nw, nh, "1565C0", "EPITHELIAL DAMAGE", "Releases alarmins: TSLP · IL-25 · IL-33");
  arrowDown(s, cx + nw/2, rows[1] + nh, 0.22);

  // 3. Dendritic cell / ILC2
  node(s, cx, rows[2], nw, nh, C.teal, "ANTIGEN PRESENTATION", "Dendritic cells → Th2 polarization  |  ILC2 activation");
  arrowDown(s, cx + nw/2, rows[2] + nh, 0.22);

  // 4. Th2 cytokine release
  node(s, cx, rows[3], nw, nh, "00695C", "Th2 / ILC2 CYTOKINES", "IL-4 · IL-5 · IL-13 · IL-9");
  arrowDown(s, cx + nw/2, rows[3] + nh, 0.22);

  // 5. IgE + Mast cell sensitization
  node(s, cx, rows[4], nw, nh, C.teal, "IgE PRODUCTION + MAST CELL SENSITIZATION", "B cells → IgE → binds FcεRI on mast cells");
  arrowDown(s, cx + nw/2, rows[4] + nh, 0.22);

  // 6. Re-exposure: mast cell degranulation
  node(s, cx, rows[5], nw, nh, C.orange, "RE-EXPOSURE → MAST CELL DEGRANULATION", "IgE cross-linking → preformed + newly synthesised mediators");
  arrowDown(s, cx + nw/2, rows[5] + nh, 0.22);

  // 7. Split label
  s.addText("BIPHASIC RESPONSE", {
    x: cx, y: rows[6] + 0.02, w: nw, h: 0.25,
    fontSize: 9, bold: true, color: C.gold, align: "center", charSpacing: 3
  });

  // ── LEFT BRANCH: Early Phase ─────────────────────────────────────────────
  const lx = 1.0;
  const bw = 3.4;
  // connector from main to left
  s.addShape("line", { x: cx, y: rows[6] + 0.28, w: -(cx - lx - bw/2 + bw/2), h: 0, line: { color: C.gold, width: 2 } });
  s.addShape("line", { x: lx + bw/2, y: rows[6] + 0.28, w: 0, h: 0.35, line: { color: C.gold, width: 2, endArrowType: "triangle" } });

  // Horizontal line at branch level
  s.addShape("line", { x: lx + bw/2, y: rows[6] + 0.28, w: cx - (lx + bw/2), h: 0, line: { color: C.gold, width: 2 } });

  node(s, lx, rows[6] + 0.63, bw, 0.7, C.orange, "EARLY PHASE  (0–30 min)",
    "Bronchoconstriction · ↑Mucus\nEdema · Vasodilation", 10, 8.5);

  // Mediators box under early phase
  s.addShape("roundRect", { x: lx, y: rows[6] + 1.42, w: bw, h: 0.72, rectRadius: 0.1, fill: { color: "3E1A00" } });
  s.addText([
    { text: "Mediators: ", options: { bold: true, color: C.gold } },
    { text: "Histamine · LTC4/D4/E4\nPGD2 · TXA2 · Acetylcholine", options: { color: "DDDDDD" } }
  ], { x: lx, y: rows[6] + 1.42, w: bw, h: 0.72, fontSize: 8.5, align: "center", valign: "middle" });

  // ── RIGHT BRANCH: Late Phase ─────────────────────────────────────────────
  const rx = 8.9;
  s.addShape("line", { x: cx + nw, y: rows[6] + 0.28, w: rx + bw/2 - (cx + nw), h: 0, line: { color: C.purple, width: 2 } });
  s.addShape("line", { x: rx + bw/2, y: rows[6] + 0.28, w: 0, h: 0.35, line: { color: C.purple, width: 2, endArrowType: "triangle" } });

  node(s, rx, rows[6] + 0.63, bw, 0.7, C.purple, "LATE PHASE  (2–8 h)",
    "Eosinophils · Neutrophils · T cells\nEpithelial damage · Persistent AHR", 10, 8.5);

  s.addShape("roundRect", { x: rx, y: rows[6] + 1.42, w: bw, h: 0.72, rectRadius: 0.1, fill: { color: "1A0033" } });
  s.addText([
    { text: "Mediators: ", options: { bold: true, color: "CE93D8" } },
    { text: "MBP · ECP · LTB4\nCharcot-Leyden crystals · ROS", options: { color: "DDDDDD" } }
  ], { x: rx, y: rows[6] + 1.42, w: bw, h: 0.72, fontSize: 8.5, align: "center", valign: "middle" });

  // ── BOTTOM: Remodeling ───────────────────────────────────────────────────
  // Arrow from center of both branches down
  const remY = rows[6] + 2.3;
  const remX = 4.3;
  const remW = 4.7;

  // converging lines
  s.addShape("line", { x: lx + bw/2, y: rows[6] + 2.14, w: 0, h: 0.16, line: { color: C.red, width: 1.5 } });
  s.addShape("line", { x: rx + bw/2, y: rows[6] + 2.14, w: 0, h: 0.16, line: { color: C.red, width: 1.5 } });
  s.addShape("line", { x: lx + bw/2, y: remY - 0.02, w: rx + bw/2 - (lx + bw/2), h: 0, line: { color: C.red, width: 1.5 } });
  s.addShape("line", { x: 6.65, y: remY - 0.02, w: 0, h: 0.25, line: { color: C.red, width: 2.5, endArrowType: "triangle" } });

  node(s, remX, remY + 0.23, remW, 0.68, C.red, "AIRWAY REMODELING  (Repeated Inflammation)",
    "Sub-BM fibrosis · ASM hypertrophy · Goblet hyperplasia · Angiogenesis · Irreversible obstruction", 10, 8);

  // Source footer
  s.addText("Source: Robbins & Cotran (10e), Fishman's Pulmonary Diseases", {
    x: 0.3, y: 7.35, w: 12.7, h: 0.2, fontSize: 7.5, color: C.dim, align: "right"
  });
}

// ═══════════════════════════════════════════════════════════════════════════
// SLIDE 3 — Cytokine & Mediator Map
// ═══════════════════════════════════════════════════════════════════════════
{
  const s = pres.addSlide();
  s.background = { color: C.bg };

  s.addShape("rect", { x: 0, y: 0, w: 13.3, h: 0.55, fill: { color: C.teal } });
  s.addText("Key Cytokines & Mediators in Asthma", {
    x: 0.2, y: 0, w: 12.9, h: 0.55, fontSize: 18, bold: true, color: C.white, valign: "middle"
  });

  // Central hub
  s.addShape("ellipse", { x: 5.4, y: 2.6, w: 2.5, h: 1.4, fill: { color: C.teal },
    shadow: { type: "outer", color: "000000", blur: 12, offset: 3, angle: 135, opacity: 0.4 }
  });
  s.addText("Th2 / ILC2\nCYTOKINE\nHUB", { x: 5.4, y: 2.6, w: 2.5, h: 1.4, fontSize: 12, bold: true, color: C.white, align: "center", valign: "middle" });

  // Surrounding nodes
  const nodes = [
    { x: 0.4,  y: 0.75, w: 2.8, h: 1.0, color: C.blue1,  title: "IL-4",       sub: "IgE class switch\nTh2 differentiation\nASM AHR ↑" },
    { x: 0.4,  y: 2.2,  w: 2.8, h: 1.0, color: C.blue2,  title: "IL-5",       sub: "Eosinophil maturation\nrecruitment & activation" },
    { x: 0.4,  y: 3.65, w: 2.8, h: 1.0, color: "1A237E",  title: "IL-13",      sub: "Goblet cell mucus ↑\nIgE production ↑\nAHR ↑" },
    { x: 0.4,  y: 5.1,  w: 2.8, h: 1.0, color: "004D40",  title: "TSLP / IL-33 / IL-25", sub: "Epithelial alarmins\nILC2 activation" },
    { x: 10.1, y: 0.75, w: 2.8, h: 1.0, color: C.orange,  title: "Leukotrienes (LTC4/D4/E4)", sub: "Prolonged bronchoconstriction\n↑Mucus · ↑Permeability" },
    { x: 10.1, y: 2.2,  w: 2.8, h: 1.0, color: "BF360C",  title: "Histamine",  sub: "Rapid bronchoconstriction\nVasodilation · Edema" },
    { x: 10.1, y: 3.65, w: 2.8, h: 1.0, color: C.purple,  title: "MBP / ECP (Eosinophils)", sub: "Epithelial necrosis\nCiliostasis · ROS" },
    { x: 10.1, y: 5.1,  w: 2.8, h: 1.0, color: "4A148C",  title: "TGF-β / VEGF / FGF-2", sub: "Airway remodeling\nFibrosis · Angiogenesis" },
  ];

  nodes.forEach(n => {
    node(s, n.x, n.y, n.w, n.h, n.color, n.title, n.sub, 11, 8.5);
    // connect to hub
    const nx_center = n.x + n.w / 2;
    const ny_center = n.y + n.h / 2;
    const hub_cx = 6.65;
    const hub_cy = 3.3;
    if (nx_center < hub_cx) {
      // left side
      s.addShape("line", { x: n.x + n.w, y: ny_center, w: hub_cx - 2.5 - (n.x + n.w), h: ny_center - hub_cy,
        line: { color: C.dim, width: 1, dashType: "dash" } });
    } else {
      s.addShape("line", { x: hub_cx + 2.5, y: hub_cy, w: n.x - (hub_cx + 2.5), h: ny_center - hub_cy,
        line: { color: C.dim, width: 1, dashType: "dash" } });
    }
  });

  s.addText("Source: Robbins & Cotran (10e)  |  Fishman's Pulmonary Diseases", {
    x: 0.3, y: 7.35, w: 12.7, h: 0.2, fontSize: 7.5, color: C.dim, align: "right"
  });
}

// ═══════════════════════════════════════════════════════════════════════════
// SLIDE 4 — Airway Remodeling Flowchart
// ═══════════════════════════════════════════════════════════════════════════
{
  const s = pres.addSlide();
  s.background = { color: C.bg };

  s.addShape("rect", { x: 0, y: 0, w: 13.3, h: 0.55, fill: { color: C.red } });
  s.addText("Airway Remodeling — Chronic Asthma", {
    x: 0.2, y: 0, w: 12.9, h: 0.55, fontSize: 18, bold: true, color: C.white, valign: "middle"
  });

  // Trigger node
  node(s, 4.9, 0.75, 3.5, 0.65, "3E0000", "REPEATED INFLAMMATION", "Persistent eosinophilic / neutrophilic infiltration");
  arrowDown(s, 6.65, 1.4, 0.25);

  // Growth factors
  node(s, 4.9, 1.65, 3.5, 0.65, "4E1010", "GROWTH FACTORS RELEASED", "TGF-β · VEGF · EGF · FGF-2 · PDGF");
  arrowDown(s, 6.65, 2.3, 0.25);

  // Five remodeling outcomes in a row
  const outcomes = [
    { color: "B71C1C", title: "Sub-BM\nFibrosis",        sub: "TGF-β → collagen\ndeposition" },
    { color: "6A1B9A", title: "ASM\nHypertrophy",         sub: "↑Contractile mass\n→ fixed AHR" },
    { color: "1565C0", title: "Goblet Cell\nHyperplasia",  sub: "IL-13/IL-4\n→ mucus plugging" },
    { color: "00695C", title: "Submucosal\nGland Hypertrophy", sub: "Cholinergic drive\n→ ↑mucus" },
    { color: "E65100", title: "Angiogenesis",              sub: "VEGF\n→ mucosal edema" },
  ];
  const startX = 0.35;
  const ow = 2.35;
  const oh = 1.1;
  const gap = 0.27;
  const outY = 2.85;

  // horizontal bar to outcomes
  s.addShape("line", { x: startX + ow/2, y: 2.55, w: (startX + ow/2) + 4*(ow+gap) - (startX + ow/2), h: 0, line: { color: C.red, width: 1.5 } });

  outcomes.forEach((o, i) => {
    const ox = startX + i * (ow + gap);
    node(s, ox, outY, ow, oh, o.color, o.title, o.sub, 10, 8);
    s.addShape("line", { x: ox + ow/2, y: 2.55, w: 0, h: 0.3, line: { color: C.red, width: 1.5, endArrowType: "triangle" } });
  });

  // converging down
  const finalY = 4.2;
  s.addShape("line", { x: startX + ow/2, y: outY + oh, w: 0, h: 0.18, line: { color: C.gold, width: 1.5 } });
  s.addShape("line", { x: startX + ow/2 + 4*(ow+gap), y: outY + oh, w: 0, h: 0.18, line: { color: C.gold, width: 1.5 } });
  s.addShape("line", { x: startX + ow/2, y: outY + oh + 0.18, w: 4*(ow+gap), h: 0, line: { color: C.gold, width: 1.5 } });
  s.addShape("line", { x: 6.65, y: outY + oh + 0.18, w: 0, h: 0.25, line: { color: C.gold, width: 2, endArrowType: "triangle" } });

  // Final outcome
  node(s, 4.2, finalY + 0.43, 5.0, 0.7, C.red, "IRREVERSIBLE (FIXED) AIRFLOW OBSTRUCTION",
    "FEV1/FVC persistently ↓  ·  Poor reversibility with bronchodilators  ·  Steroid resistance", 11, 8.5);

  // Comparison table
  const ty = 5.45;
  s.addShape("rect", { x: 0.5, y: ty, w: 12.3, h: 0.35, fill: { color: C.blue1 } });
  s.addText("Reversible vs Irreversible Obstruction", { x: 0.5, y: ty, w: 12.3, h: 0.35, fontSize: 11, bold: true, color: C.white, align: "center", valign: "middle" });

  const rows2 = [
    ["Feature", "Reversible (Acute)", "Irreversible (Remodeled)"],
    ["Bronchodilator response", "≥12% + 200 mL ↑ in FEV1", "< 12% improvement"],
    ["Dominant pathology", "Bronchoconstriction + mucus", "Fibrosis + muscle hypertrophy"],
    ["Steroid response", "Good (ICS effective)", "Partial or resistant"],
    ["Typical phase", "Early / acute attack", "Severe chronic asthma"],
  ];
  const rh = 0.28;
  const colW = [3.2, 4.55, 4.55];
  const colX = [0.5, 3.7, 8.25];
  rows2.forEach((row, ri) => {
    const rowY = ty + 0.35 + ri * rh;
    const bg = ri === 0 ? "1A2E4A" : (ri % 2 === 0 ? "162035" : "0D1B2A");
    s.addShape("rect", { x: 0.5, y: rowY, w: 12.3, h: rh, fill: { color: bg } });
    row.forEach((cell, ci) => {
      s.addText(cell, {
        x: colX[ci] + 0.05, y: rowY, w: colW[ci] - 0.1, h: rh,
        fontSize: ri === 0 ? 9 : 8.5,
        bold: ri === 0,
        color: ri === 0 ? C.gold : C.lt,
        valign: "middle"
      });
    });
    // vertical dividers
    s.addShape("line", { x: 3.7, y: rowY, w: 0, h: rh, line: { color: C.dim, width: 0.5 } });
    s.addShape("line", { x: 8.25, y: rowY, w: 0, h: rh, line: { color: C.dim, width: 0.5 } });
  });

  s.addText("Source: Robbins & Cotran (10e)  |  Fishman's Pulmonary Diseases", {
    x: 0.3, y: 7.35, w: 12.7, h: 0.2, fontSize: 7.5, color: C.dim, align: "right"
  });
}

// ═══════════════════════════════════════════════════════════════════════════
// SLIDE 5 — AHR + Biphasic Response detail
// ═══════════════════════════════════════════════════════════════════════════
{
  const s = pres.addSlide();
  s.background = { color: C.bg };

  s.addShape("rect", { x: 0, y: 0, w: 13.3, h: 0.55, fill: { color: C.orange } });
  s.addText("Biphasic Bronchial Response & AHR Mechanisms", {
    x: 0.2, y: 0, w: 12.9, h: 0.55, fontSize: 18, bold: true, color: C.white, valign: "middle"
  });

  // LEFT: Early Phase
  s.addShape("rect", { x: 0.3, y: 0.7, w: 5.9, h: 0.38, fill: { color: C.orange } });
  s.addText("EARLY PHASE  (Minutes 0–30)", { x: 0.3, y: 0.7, w: 5.9, h: 0.38, fontSize: 13, bold: true, color: C.white, align: "center", valign: "middle" });

  const earlyItems = [
    { icon: "▶", text: "IgE cross-linking → mast cell degranulation" },
    { icon: "▶", text: "Histamine & LTC4/D4/E4 release" },
    { icon: "▶", text: "Direct ASM contraction" },
    { icon: "▶", text: "Vagal reflex bronchoconstriction (subepithelial receptors)" },
    { icon: "▶", text: "↑ Vascular permeability → mucosal edema" },
    { icon: "▶", text: "Goblet cell activation → mucus hypersecretion" },
  ];
  earlyItems.forEach((item, i) => {
    s.addShape("rect", { x: 0.3, y: 1.1 + i * 0.45, w: 5.9, h: 0.4, fill: { color: i % 2 === 0 ? "2A1500" : "1E1000" } });
    s.addText(item.icon + "  " + item.text, { x: 0.4, y: 1.1 + i * 0.45, w: 5.7, h: 0.4, fontSize: 9.5, color: C.lt, valign: "middle" });
  });

  // RIGHT: Late Phase
  s.addShape("rect", { x: 7.1, y: 0.7, w: 5.9, h: 0.38, fill: { color: C.purple } });
  s.addText("LATE PHASE  (Hours 2–8)", { x: 7.1, y: 0.7, w: 5.9, h: 0.38, fontSize: 13, bold: true, color: C.white, align: "center", valign: "middle" });

  const lateItems = [
    { icon: "▶", text: "Chemokines recruit eosinophils, neutrophils, T cells" },
    { icon: "▶", text: "Eosinophils release MBP, ECP → epithelial damage" },
    { icon: "▶", text: "Charcot-Leyden crystals → further inflammation" },
    { icon: "▶", text: "LTB4 → sustained neutrophil recruitment" },
    { icon: "▶", text: "Persistent AHR (airway hyperresponsiveness)" },
    { icon: "▶", text: "Sets stage for structural remodeling" },
  ];
  lateItems.forEach((item, i) => {
    s.addShape("rect", { x: 7.1, y: 1.1 + i * 0.45, w: 5.9, h: 0.4, fill: { color: i % 2 === 0 ? "150025" : "0D0018" } });
    s.addText(item.icon + "  " + item.text, { x: 7.2, y: 1.1 + i * 0.45, w: 5.7, h: 0.4, fontSize: 9.5, color: C.lt, valign: "middle" });
  });

  // Divider
  s.addShape("line", { x: 6.65, y: 0.7, w: 0, h: 2.8, line: { color: C.gold, width: 1.5, dashType: "dash" } });
  s.addText("VS", { x: 6.3, y: 1.95, w: 0.7, h: 0.4, fontSize: 12, bold: true, color: C.gold, align: "center" });

  // AHR mechanisms
  s.addShape("rect", { x: 0.3, y: 3.85, w: 12.7, h: 0.38, fill: { color: "1A3A1A" } });
  s.addText("AIRWAY HYPERRESPONSIVENESS (AHR) — Mechanisms", {
    x: 0.3, y: 3.85, w: 12.7, h: 0.38, fontSize: 13, bold: true, color: "A5D6A7", align: "center", valign: "middle"
  });

  const ahrItems = [
    "Exposed subepithelial sensory nerves → exaggerated reflex bronchoconstriction",
    "ASM hypertrophy + hyperplasia → ↑ contractile mass",
    "↑ Mucosal permeability → deeper allergen penetration",
    "Neural plasticity: ↑ Substance P, VIP changes",
    "Persistent eosinophilic inflammation lowers ASM threshold",
    "Epithelial damage → loss of bronchodilating epithelium-derived factor (EpDRF)",
  ];
  const ahrPerRow = 3;
  ahrItems.forEach((item, i) => {
    const col = i % ahrPerRow;
    const row = Math.floor(i / ahrPerRow);
    const ax = 0.3 + col * 4.25;
    const ay = 4.3 + row * 0.85;
    s.addShape("roundRect", { x: ax, y: ay, w: 4.15, h: 0.75, rectRadius: 0.1, fill: { color: "0A2A0A" } });
    s.addText("✦  " + item, { x: ax + 0.1, y: ay, w: 3.95, h: 0.75, fontSize: 8.5, color: "C8E6C9", valign: "middle" });
  });

  s.addText("Source: Robbins & Cotran (10e)  |  Fishman's Pulmonary Diseases", {
    x: 0.3, y: 7.35, w: 12.7, h: 0.2, fontSize: 7.5, color: C.dim, align: "right"
  });
}

// ═══════════════════════════════════════════════════════════════════════════
// Write file
// ═══════════════════════════════════════════════════════════════════════════
pres.writeFile({ fileName: "/home/daytona/workspace/asthma-ppt/Asthma_Pathophysiology_Flowchart.pptx" })
  .then(() => console.log("Done: Asthma_Pathophysiology_Flowchart.pptx"))
  .catch(e => { console.error(e); process.exit(1); });

You've run out of free credits. Sign up for a free account to continue using Orris.

This is a shared conversation. Sign in to Orris to start your own chat.